J. Feld
New England Journal of Medicine · 2005–2015
A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom J. Feld trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts J. Feld overall
Papers from J. Feld's perspective
Ordered by how strongly the researchers J. Feld trusts endorse each paper. Same corpus, a different order for every researcher.
- Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. (Proceedings of the National Academy of Sciences of the United States of America)
- Viruses and interferons. (Annual Review of Microbiology)
- Functional classification of interferon‐stimulated genes identified using microarrays (Journal of Leukocyte Biology)
- Complete Replication of Hepatitis C Virus in Cell Culture (Science)
- Robust hepatitis C virus infection in vitro. (Proceedings of the National Academy of Sciences of the United States of America)
- Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (Nature Medicine)
- Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus (Journal of Experimental Medicine)
- Global Distribution and Prevalence of Hepatitis C Virus Genotypes (Hepatology)
- Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-I (Journal of Virology)
- Immunology of hepatitis B virus and hepatitis C virus infection (Nature reviews. Immunology)
Their papers
- Hepatitis C virus infection (2015) — 1,016 citations
- Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection. (2015) — 1,329 citations
- Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin. (2014) — 979 citations
- Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. (2013) — 1,172 citations
- Mechanism of action of interferon and ribavirin in treatment of hepatitis C (2005) — 1,041 citations